NCT06528158 Speech Groups for Children Living With a Sibling Who Suffers From Anorexia Nervosa
| NCT ID | NCT06528158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-01-02 |
| Primary Completion | 2026-08-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 24 participants in total. It began in 2025-01-02 with a primary completion date of 2026-08-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anorexia nervosa (AN) is a complex mental disease with a huge impact on the patient's siblings life and well-being. Based on literature, group interventions for siblings of children suffering from a chronic disease could provide an effective support. A few have been studied, and even fewer exist for siblings of children with AN.
Eligibility Criteria
* inclusion criteria : Sibling presenting a DSM (Diagnostic and Statistical Manual)-5 of Mental Disorders diagnosis of AN, and engaged in inpatient or outpatient healthcare * exclusion criteria : * (1) Opposition from the participant and/or from their legal representatives. * (2) Non-fluent French speaker * (3) Clinical presentation not compatible with the group sessions
Contact & Investigator
Antoine STOCKER, MD
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT06528158 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06528158 currently recruiting?
Yes, NCT06528158 is actively recruiting participants. Contact the research team at stocker.a@chu-toulouse.fr for enrollment information.
Where is the NCT06528158 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT06528158 clinical trial?
NCT06528158 is sponsored by University Hospital, Toulouse. The principal investigator is Antoine STOCKER, MD at University Hospital, Toulouse. The trial plans to enroll 24 participants.